Home > Boards > US Listed > Medical - Drugs > Eli Lilly & Company (LLY)

I am going to pick up some NSAV

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
RSI38 Member Profile
Member Level 
Followed By 63
Posts 5,456
Boards Moderated 0
Alias Born 08/19/09
160x600 placeholder
Lilly's CYRAMZA® (ramucirumab) Receives FDA Approval as First-Line Treatment for Metastatic EGFR-Mutated Non-Small Cell Lung... PR Newswire (US) - 5/29/2020 9:07:00 PM
Lilly Receives U.S. FDA Approval of TAUVID™ (flortaucipir F 18 injection) for Use in Patients Being Evaluated for Alzheimer... PR Newswire (US) - 5/28/2020 7:17:00 PM
Statement from Lilly Chairman and CEO Dave Ricks on New Part D Senior Savings Model PR Newswire (US) - 5/26/2020 5:51:00 PM
Eli Lilly, Boehringer Ingelheim to Study Diabetes Drug Jardiance After Heart Attacks Dow Jones News - 5/26/2020 1:15:00 PM
Nature Publishes Preclinical Characterization and Primate Efficacy Data on Junshi Biosciences’ COVID-19 Neutralizing Antibo... GlobeNewswire Inc. - 5/26/2020 10:11:01 AM
Boehringer Ingelheim and Lilly to collaborate with Duke Clinical Research Institute on a pragmatic trial examining Jardiance'... PR Newswire (US) - 5/26/2020 8:00:00 AM
Emgality® Shows Improvement in Work Productivity and Health and Well-Being Between Attacks in Patients with Migraine and a H... PR Newswire (US) - 5/26/2020 6:45:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/20/2020 9:09:24 AM
Results of GERAS-US Study Demonstrate Societal Cost Burden for Patients and Caregivers During Early Stages of Alzheimer's Dis... PR Newswire (US) - 5/19/2020 9:00:00 AM
Lilly Oncology Showcases Innovation in Cancer Research at ASCO 2020 PR Newswire (US) - 5/13/2020 5:00:00 PM
Mail-Order Drug Delivery Rises During Coronavirus Lockdowns Dow Jones News - 5/12/2020 7:29:00 AM
Drug Sales To Doctors Forced to Go Virtual -- WSJ Dow Jones News - 5/12/2020 3:02:00 AM
Drugmakers Overhaul the Sales Pitch Amid Coronavirus Lockdowns Dow Jones News - 5/11/2020 7:29:00 AM
Lilly Receives U.S. FDA Approval for Retevmo™ (selpercatinib), the First Therapy Specifically for Patients with Advanced RE... PR Newswire (US) - 5/8/2020 8:22:00 PM
FDA Approves Eli Lilly Subsidiary's Retevmo to Treat Certain Cancer Patients Dow Jones News - 5/8/2020 6:28:00 PM
Eli Lilly Says Higher Trulicity Doses Reduced A1C, Weight in People with Type 2 Diabetes Dow Jones News - 5/8/2020 3:45:00 PM
Higher investigational doses of Trulicity® (dulaglutide) meaningfully reduced A1C and body weight in people with type 2 diab... PR Newswire (US) - 5/8/2020 2:20:00 PM
Tyvyt® (Sintilimab Injection) Combined with Gemzar® (Gemcitabine for Injection) and Platinum Chemotherapy Met the Predefine... PR Newswire (US) - 5/6/2020 7:30:00 PM
Lilly to Participate in UBS Virtual Global Healthcare Conference PR Newswire (US) - 5/5/2020 4:30:00 PM
Specialized Disclosure Report (sd) Edgar (US Regulatory) - 5/5/2020 1:59:51 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/5/2020 1:47:20 PM
Lilly Declares Second-Quarter 2020 Dividend PR Newswire (US) - 5/4/2020 3:00:00 PM
Junshi Biosciences and Lilly to Co-develop Antibody Therapies for the Prevention and Treatment of COVID-19 GlobeNewswire Inc. - 5/4/2020 9:14:00 AM
Lilly and Junshi Biosciences to Co-develop Antibody Therapies for the Prevention and Treatment of COVID-19 PR Newswire (US) - 5/4/2020 8:00:00 AM
Shanghai Junshi Biosciences, Eli Lilly Ink Covid-19 Deal Dow Jones News - 5/3/2020 8:58:00 PM
RSI38 Member Level  Thursday, 12/21/17 03:11:27 PM
Re: RSI38 post# 91
Post # of 101 
I am going to pick up some NSAV shares before this takes off on this HUUUGE news with LLY.




Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist